Romosozumab and cardiovascular safety-should we learn lessons from pioglitazone? Jacob JJ, Paul TV. Osteoporos Int 2022;33:1397-1399.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jacob JJ, Paul TV. Romosozumab and cardiovascular safety-should we learn lessons from pioglitazone? Osteoporos Int 2022;33:1397-1399.
PMID: 35181823